0
Clinical Investigations: ASTHMA |

Effects of Adding Either a Leukotriene Receptor Antagonist or Low-Dose Theophylline to a Low or Medium Dose of Inhaled Corticosteroid in Patients With Persistent Asthma*

Owen J. Dempsey, MBChB; Stephen J. Fowler, MBChB; Andrew Wilson, MD; Gwen Kennedy, PhD; Brian J. Lipworth, MD
Author and Funding Information

*From the Asthma and Allergy Research Group (Drs. Dempsey, Fowler, Wilson, and Lipworth), Department of Clinical Pharmacology & Therapeutics, and the Department of Medicine (Dr. Kennedy), Section of Vascular Medicine & Biology, Ninewells Hospital and Medical School, University of Dundee, Dundee, Scotland, UK.

Correspondence to: Brian J. Lipworth, MD, Professor of Allergy and Pulmonology, Asthma and Allergy Research Group, Department of Clinical Pharmacology & Therapeutics, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland; e-mail: b.j.lipworth@dundee.ac.uk



Chest. 2002;122(1):151-159. doi:10.1378/chest.122.1.151
Text Size: A A A
Published online

Study objectives: To evaluate the effect of adding zafirlukast or low-dose theophylline to a beclomethasone dipropionate (BDP) extra-fine hydrofluoroalkane aerosol on bronchial hyperresponsiveness as the primary outcome variable.

Methods: Twenty-four patients with mild-to-moderate asthma were studied using a randomized crossover design with the following three treatment blocks: (1) beclomethasone, 100 μg/d, alone for the first 2 weeks followed by 400 μg/d alone for the next 2 weeks; (2) beclomethasone, 100 μg/d, followed by 400 μg/d, with the addition of zafirlukast, 20 mg bid; (3) beclomethasone, 100 μg/d, followed by 400 μg/d, with the addition of theophylline, 200 to 300 mg bid. Measurements were made after 2 and 4 weeks of each treatment and at pretreatment baseline.

Results: The mean trough plasma theophylline concentration was 6.7 mg/L, coinciding with the anti-inflammatory target range (ie, 5 to 10 mg/L). The provocative dose of methacholine causing a 20% fall in FEV1 (as doubling dose difference from baseline) was significantly (p < 0.05) greater with beclomethasone, 100 μg, plus zafirlukast (1.1 doubling dose) but not with beclomethasone, 100 μg, plus theophylline (0.7 doubling dose) compared to beclomethasone, 100 μg alone (0.4 doubling dose), but not compared to beclomethasone, 400 μg alone (1.1 doubling dose). There were also significant (p < 0.05) differences between beclomethasone, 100 μg, plus zafirlukast (but not BDP, 100 μg, plus theophylline) vs beclomethasone, 100 μg, alone in terms of nitric oxide level, midexpiratory phase of forced expiratory flow, and peak expiratory flow. There were no further significant improvements observed with the addition of zafirlukast or theophylline to beclomethasone, 400 μg.

Conclusions: A leukotriene receptor antagonist, but not low-dose theophylline, conferred significant additive anti-inflammatory effects to therapy with a low-dose inhaled corticosteroid but not to that with a medium dose of an inhaled corticosteroid. Thus, optimizing the dose of inhaled corticosteroid as monotherapy would seem to be the logical first step, which is in keeping with current guidelines.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
The acute management of asthma. Clin Rev Allergy Immunol 2015;48(1):114-25.
Guidelines
Asthma in pregnancy.
American College of Obstetricians and Gynecologists | 9/19/2008
Management of asthma.
Singapore Ministry of Health | 7/18/2008
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543